Suchergebnisse - "STK11"

PubPharm (1.938)

1

Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Caballé-Perez, E. | Hernández-Pedro, N. | Ramos-Ramírez, M. | +7

2

Cellular and molecular characteristics of stromal Lkb1 deficiency-induced gastrointestinal polyposis based on single-cell RNA sequencing

enthalten in: The Journal of pathology | 2024

von Cai, Z. | Jiang, Y. | Tong, H. | +12

3

Dapagliflozin promotes browning of white adipose tissue through the FGFR1-LKB1-AMPK signaling pathway

enthalten in: Molecular biology reports | 2024

von Lv, Y. | Zhao, C. | Jiang, Q. | +7

4

Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer : a comprehensive study based on meta-analyses and bioinformatics analyses

enthalten in: BMC cancer | 2024

von Xu, K. | Lu, W. | Yu, A. | +2

5

Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses

enthalten in: BMC cancer | 2024

von Xu, K. | Lu, W. | Yu, A. | +2

6

Two missense STK11 gene variations impaired LKB1/adenosine monophosphate-activated protein kinase signaling in Peutz-Jeghers syndrome

enthalten in: World journal of gastrointestinal oncology | 2024

von Liu, J. | Zeng, S. | Wang, A. | +3

7

Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort

enthalten in: Tumori | 2024

von Olsen, A. | Lebedeva, A. | Nosova, P. | +5

8

STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Baptiste Oudart, J. | Garinet, S. | Leger, C. | +11

9

Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Sun, L. | Handorf, E. | Zhou, Y. | +3

10

Liprin-α1 contributes to oncogenic MAPK signaling by counteracting ERK activity

enthalten in: Molecular oncology | 2024

von Pehkonen, H. | Filippou, A. | Väänänen, J. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[194]